日韩欧美中文字幕在线韩

  • <pre id="0xn3r"></pre>
  • <acronym id="0xn3r"><label id="0xn3r"><address id="0xn3r"></address></label></acronym>
    <td id="0xn3r"></td>
    <acronym id="0xn3r"><strong id="0xn3r"><listing id="0xn3r"></listing></strong></acronym>
    1. 【強強聯手】 源資信息科技(上海)有限公司宣布與TDV成為戰略合作伙伴!

      2021-09-06 13:34:37 來源:源資信息科技(上海)有限公司

      2021年9月6日,源資信息科技(上海)有限公司(以下簡稱"源資科技")與上海韜維醫藥咨詢有限公司(以下簡稱“TDV”)達成戰略合作,雙方將充分發揮各自在行業內的優勢,持續為中國生命科學領域的客戶提供更專業的信息化建設及GxP咨詢服務!

      On 6th September 2021, Tri-I Biotech (Shanghai) Ltd. (referred to as Tri-I) and Shanghai TDV Pharmaceutical Consulting Co. Ltd.(referred to as TDV)reached strategic cooperation which will leverage each other’s strengths in the life science industry and deliver further professional informatics support and GxP consultancy service!

       

      面對COVID19后疫情時代,中國健康醫療法規政策更趨向成熟及全球藥品供應鏈新藥、疫苗與新療法研發及出口至多國市場等需求,這對國內既存醫藥公司或新藥創業型公司來說,無疑是一場需要快速提升合規質量與法規的變革。

      In post-COVID19, China domestic healthcare policy is becoming more mature, and the part China plays in global drug supply chain is growing. The demands of launching in multi-markets to new drugs/vaccines/therapies developing companies is rapidly increasing. It brings a revolution in the compliance aspect of quality and regulatory to existing biopharma companies or new drug start-up enterprises in China.

       

      “源資科技擁有十多年智能化信息服務落地實施與驗證經驗, 深刻了解國內企業在原先體制與面對審計合規之間的落差”,源資科技總經理李旻熹先生表示:“生命科學公司面臨著嚴格的監管要求等挑戰,因此同時也需要對其行業具有深刻理解和業務經驗的合作伙伴?!?/em>

      “Tri-I with more than 10 years experiences on project implantation and validation in China, and we’ve been aware that there’s a gap between the existing systems of China enterprises and regulatory compliance.” Said Michael Lee, General manager of Tri-I. “Life sciences companies currently face unique challenges of strict regulatory guidelines and requirements. Therefore, it’s significant to work with a right partner that has a deep understanding and rich experience in pharmaceutical and life science industry.”

       

      TDV總經理Octavi Colomina認為:“TDV有二十多年咨詢全球各市場合規的經驗, 結合源資科技在國內多年智能化信息系統實施落地經驗, 將共同為中國生技制藥行業創造不一樣的知識價值?!?/em>

      “ This partnership will provide the best value of the knowledge to China Biotech/Pharmaceutical Industry, through TDV’s extensive experience with global partners with over 20 years and Tri-I’s digital solution implementation experiences.” declared Octavi Colomina, General manager of TDV.

       

      源資科技本著企業初衷, 為成為國內生命科學領域的核心合作伙伴, 已經站在全球藥品市場視野上, 加速國內伙伴不論在企業內的信息化轉型, 智能化系統面的GxP合規之外, 包含自研發GxP到準備各國法規體系審計, 都能給我們的伙伴提供全方位優質的專業服務。今年進入COVID19后疫情時代, 也凸顯了國內制藥企業在全球藥品供應鏈的重要性, 源資科技也將繼續支持我們的伙伴一起共創共榮, 迎來新的產業浪潮。

      The intention of establishing Tri-I Biotech is to become a core partner of pharmaceutical and life science companies in Greater China. Tri-I Biotech aims to support clients to step on their digital transformation journey. Tri-I Biotech helps clients to prepare for inspection/auditions in different markets and become GxP compliance on informatics system.  2021 is a post-Covid19 year, it highlights an importance role of domestic pharmaceutical companies in the global pharmaceutical supply chain. Tri-I will continually assist our clients to bring all-wins together in order to welcome the new global industry waving!

       

      關于TDV/About TDV

      TDV 是自1997 年成立的一家專業于 GxP 合規咨詢公司,總部位于西班牙;自 2006 年起通過其當地分支機構在中國上海開展業務。 TDV 為制藥、生物技術、醫療器械或化妝品等各個行業的公司提供質量和合規方面的咨詢服務與良好實踐 (GXP)、驗證、業務流程的數字化轉型以及公司知識管理。

      其提供專業的 GxP(GMP、GLP、GCP、GDP)重點項目咨詢:指導企業能有適當質量體系、驗證方法以成功滿足世界各地衛生監管當局(EMA、FDA、NMPA)制定等要求。 此外,TDV 在制藥、醫療器械和生物技術行業及相關行業已擁有 200 多家客戶:服務產業覆蓋原物料 和精工化學品、批發商、實驗室、CRO、軟件開發商等。

      TDV is a GxP compliance consulting company with headquarters in Spain since 1997 and operating in ShangHai China through its local affiliate since 2006.  TDV advises companies in various sectors – pharmaceutical, biotechnology, medical devices, or cosmetics – in the areas of quality and compliance with good practices (GxP), validation, digital transformation of their processes, and knowledge management in the company.

      It provides professional key projects in GxP (GMP, GLP, GCP, GDP) consultancy: have the appropriate quality systems, and validation approach to successfully fulfil the requirements established by the Health Authorities around the world (EMA, FDA, NMPA, etc.). Also, TDV has more than 200 customers in Pharma, Med Device and Biotech industries as well as related industries: API and fine chemicals, wholesalers, laboratories, CROs, software developers, etc

       

      關于源資科技/About Tri-I Biotech

      源資信息科技(上海)有限公司是中國領先的信息化產品和整體解決方案服務供應商,成立于2008年5月。源資科技的目標是以提供AI計算模擬、基于大數據的智能質量信息管理和自動化臨床電子化等創新理念提供的整體解決方案,加速各客戶在制藥、化工和材料領域的發展。源資科技正不斷擴大其服務范圍,從生命科學到材料科學,從實施、驗證服務到定制開發。源資科技的成功取決于專業團隊和他們不懈精神并不斷為客戶帶來建設性的想法和貢獻。

      Tri-I Biotech (Shanghai) Ltd. is a leading informatics products and total solutions service provider in China and was founded in May 2008. Tri-I’s goal is to accelerate clients’ development with innovative concepts in the pharmaceutical, chemical and material industry by providing the total solution of AI-enabled computing simulation, big data-based intelligent quality informatics management, and automatic clinical digitalization. Tri-I is continually enlarging its service range, from life science to material science; from implementation, validation service to customized solutions. The success of Tri-I relies on our professional team and their perseverance. Tri-I has continuously brought constructive ideas and contributions to clients in pharmaceutical, chemical engineering, and materials fields.


      Copyright ? 2008 - 2021 Tri-ibiotech.com All Right Reserved. | 備案許可證: 滬ICP備11020704-5.
      日韩欧美中文字幕在线韩